Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Virus-mediated mRNA decay by hyperadenylation.

Sokoloski KJ, Chaskey EL, Wilusz J.

Genome Biol. 2009;10(8):234. doi: 10.1186/gb-2009-10-8-234. Epub 2009 Aug 11. Review.

2.

Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction.

Lee YJ, Glaunsinger BA.

PLoS Biol. 2009 May 5;7(5):e1000107. doi: 10.1371/journal.pbio.1000107. Epub 2009 May 26.

3.

A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts.

Conrad NK, Steitz JA.

EMBO J. 2005 May 18;24(10):1831-41. Epub 2005 Apr 28.

4.

Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication.

Boyne JR, Colgan KJ, Whitehouse A.

PLoS Pathog. 2008 Oct;4(10):e1000194. doi: 10.1371/journal.ppat.1000194. Epub 2008 Oct 31.

5.

Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export.

Nekorchuk M, Han Z, Hsieh TT, Swaminathan S.

J Virol. 2007 Sep;81(18):9990-8. Epub 2007 Jul 3.

6.

Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA.

Kumar GR, Glaunsinger BA.

Mol Cell Biol. 2010 Nov;30(21):4996-5008. doi: 10.1128/MCB.00600-10. Epub 2010 Sep 7.

7.
8.

Canonical Poly(A) Polymerase Activity Promotes the Decay of a Wide Variety of Mammalian Nuclear RNAs.

Bresson SM, Hunter OV, Hunter AC, Conrad NK.

PLoS Genet. 2015 Oct 20;11(10):e1005610. doi: 10.1371/journal.pgen.1005610. eCollection 2015 Oct.

9.

A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression.

Borah S, Darricarrère N, Darnell A, Myoung J, Steitz JA.

PLoS Pathog. 2011 Oct;7(10):e1002300. doi: 10.1371/journal.ppat.1002300. Epub 2011 Oct 13.

10.

Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, Rosenthal LJ.

J Clin Virol. 2000 May;16(3):203-13.

PMID:
10738139
11.

Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59.

Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM.

J Virol. 2011 Feb;85(4):1528-40. doi: 10.1128/JVI.01709-10. Epub 2010 Nov 24.

12.

The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.

Wies E, Hahn AS, Schmidt K, Viebahn C, Rohland N, Lux A, Schellhorn T, Holzer A, Jung JU, Neipel F.

J Biol Chem. 2009 Mar 27;284(13):8525-38. doi: 10.1074/jbc.M809252200. Epub 2009 Jan 7.

13.

Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells.

Davis MA, Stürzl MA, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ.

J Natl Cancer Inst. 1997 Dec 17;89(24):1868-74.

PMID:
9414174
15.

Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Sahin BB, Patel D, Conrad NK.

PLoS Pathog. 2010 Mar 5;6(3):e1000799. doi: 10.1371/journal.ppat.1000799.

16.
17.

Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.

Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM.

J Virol. 1996 Nov;70(11):8218-23.

20.

Supplemental Content

Support Center